COPENHAGEN |
Wed Feb 16, 2011 2:49am EST
COPENHAGEN (Reuters) - Denmark's Novo Nordisk said on Wednesday it had received a subpoena in the United States regarding potential criminal offences relating to marketing and promotion practices for a number of its products.
The world's biggest maker of insulin said in a statement that the office of the United States attorney for the District of Massachusetts had asked for documents relating to Novo Nordisk's
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment